G-protein coupled receptor kinase (GRK)-5 regulates proliferation of glioblastoma-derived stem cells

Gurvinder Kaur, Joseph Kim, Rajwant Kaur, Ili Tan, Orin Bloch, Matthew Z. Sun, Michael Safaee, Michael C. Oh, Michael Sughrue, Joanna Phillips, Andrew T. Parsa

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Glioblastoma multiforme (GBM) is a grade IV malignant brain tumor with high mortality and has been well known to involve many molecular pathways, including G-protein coupled receptor (GPCR)-mediated signaling (such as epithelial growth factor receptor [EGFR] and platelet derived growth factor receptor [PDGFR]). G protein-coupled receptor kinases (GRK) directly regulate GPCR activity by phosphorylating activated agonist-bound receptors to desensitize signaling and internalize receptors through beta-arrestins. Recent studies in various cancers, including prostate and breast cancer, have highlighted the role of change in GRK expression to oncogenesis and tumor proliferation. In this study, we evaluated the expression of GRK5 in grade II to grade IV glioma specimens using immunohistochemistry and found that GRK5 expression levels are highly correlated with aggressiveness of glioma. We used culture conditions to selectively promote the growth of either glioblastoma cells with stem cell markers (GSC) or differentiated glioblastoma cells (DGC) from fresh GBM specimens. GSC are known to be highly invasive and mobile, and have the capacity to self-renew and are more resistant to chemotherapy and radiation compared to differentiated populations of GBM. We examined the expression of GRK5 in these two sets of culturing conditions for GBM cells and found that GRK5 expression is upregulated in GSC compared to differentiated GBM cells. To better understand the role of GRK5 in GBM-derived stem cells, we created stable GRK5 knockdown and evaluated the proliferation rate. Using an ATP chemiluminescence assay, we show, for the first time, that knocking down the expression of GRK5 decreased the proliferation rate of GSC in contrast to control.

Original languageEnglish (US)
Pages (from-to)1014-1018
Number of pages5
JournalJournal of Clinical Neuroscience
Volume20
Issue number7
DOIs
StatePublished - Jul 1 2013
Externally publishedYes

Fingerprint

G-Protein-Coupled Receptor Kinase 5
Glioblastoma
Stem Cells
G-Protein-Coupled Receptor Kinases
G-Protein-Coupled Receptors
Glioma
Prostatic Neoplasms
Breast Neoplasms
Platelet-Derived Growth Factor Receptors
Growth Factor Receptors
Luminescence
Brain Neoplasms
Carcinogenesis
Adenosine Triphosphate
Immunohistochemistry

Keywords

  • GBM
  • Glioblastoma derived stem cells
  • GRK
  • Proliferation

ASJC Scopus subject areas

  • Surgery
  • Neurology
  • Clinical Neurology
  • Physiology (medical)

Cite this

G-protein coupled receptor kinase (GRK)-5 regulates proliferation of glioblastoma-derived stem cells. / Kaur, Gurvinder; Kim, Joseph; Kaur, Rajwant; Tan, Ili; Bloch, Orin; Sun, Matthew Z.; Safaee, Michael; Oh, Michael C.; Sughrue, Michael; Phillips, Joanna; Parsa, Andrew T.

In: Journal of Clinical Neuroscience, Vol. 20, No. 7, 01.07.2013, p. 1014-1018.

Research output: Contribution to journalArticle

Kaur, G, Kim, J, Kaur, R, Tan, I, Bloch, O, Sun, MZ, Safaee, M, Oh, MC, Sughrue, M, Phillips, J & Parsa, AT 2013, 'G-protein coupled receptor kinase (GRK)-5 regulates proliferation of glioblastoma-derived stem cells', Journal of Clinical Neuroscience, vol. 20, no. 7, pp. 1014-1018. https://doi.org/10.1016/j.jocn.2012.10.008
Kaur, Gurvinder ; Kim, Joseph ; Kaur, Rajwant ; Tan, Ili ; Bloch, Orin ; Sun, Matthew Z. ; Safaee, Michael ; Oh, Michael C. ; Sughrue, Michael ; Phillips, Joanna ; Parsa, Andrew T. / G-protein coupled receptor kinase (GRK)-5 regulates proliferation of glioblastoma-derived stem cells. In: Journal of Clinical Neuroscience. 2013 ; Vol. 20, No. 7. pp. 1014-1018.
@article{1fe3c8fd1b5b4e91ac779a3eb6808481,
title = "G-protein coupled receptor kinase (GRK)-5 regulates proliferation of glioblastoma-derived stem cells",
abstract = "Glioblastoma multiforme (GBM) is a grade IV malignant brain tumor with high mortality and has been well known to involve many molecular pathways, including G-protein coupled receptor (GPCR)-mediated signaling (such as epithelial growth factor receptor [EGFR] and platelet derived growth factor receptor [PDGFR]). G protein-coupled receptor kinases (GRK) directly regulate GPCR activity by phosphorylating activated agonist-bound receptors to desensitize signaling and internalize receptors through beta-arrestins. Recent studies in various cancers, including prostate and breast cancer, have highlighted the role of change in GRK expression to oncogenesis and tumor proliferation. In this study, we evaluated the expression of GRK5 in grade II to grade IV glioma specimens using immunohistochemistry and found that GRK5 expression levels are highly correlated with aggressiveness of glioma. We used culture conditions to selectively promote the growth of either glioblastoma cells with stem cell markers (GSC) or differentiated glioblastoma cells (DGC) from fresh GBM specimens. GSC are known to be highly invasive and mobile, and have the capacity to self-renew and are more resistant to chemotherapy and radiation compared to differentiated populations of GBM. We examined the expression of GRK5 in these two sets of culturing conditions for GBM cells and found that GRK5 expression is upregulated in GSC compared to differentiated GBM cells. To better understand the role of GRK5 in GBM-derived stem cells, we created stable GRK5 knockdown and evaluated the proliferation rate. Using an ATP chemiluminescence assay, we show, for the first time, that knocking down the expression of GRK5 decreased the proliferation rate of GSC in contrast to control.",
keywords = "GBM, Glioblastoma derived stem cells, GRK, Proliferation",
author = "Gurvinder Kaur and Joseph Kim and Rajwant Kaur and Ili Tan and Orin Bloch and Sun, {Matthew Z.} and Michael Safaee and Oh, {Michael C.} and Michael Sughrue and Joanna Phillips and Parsa, {Andrew T.}",
year = "2013",
month = "7",
day = "1",
doi = "10.1016/j.jocn.2012.10.008",
language = "English (US)",
volume = "20",
pages = "1014--1018",
journal = "Journal of Clinical Neuroscience",
issn = "0967-5868",
publisher = "Churchill Livingstone",
number = "7",

}

TY - JOUR

T1 - G-protein coupled receptor kinase (GRK)-5 regulates proliferation of glioblastoma-derived stem cells

AU - Kaur, Gurvinder

AU - Kim, Joseph

AU - Kaur, Rajwant

AU - Tan, Ili

AU - Bloch, Orin

AU - Sun, Matthew Z.

AU - Safaee, Michael

AU - Oh, Michael C.

AU - Sughrue, Michael

AU - Phillips, Joanna

AU - Parsa, Andrew T.

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Glioblastoma multiforme (GBM) is a grade IV malignant brain tumor with high mortality and has been well known to involve many molecular pathways, including G-protein coupled receptor (GPCR)-mediated signaling (such as epithelial growth factor receptor [EGFR] and platelet derived growth factor receptor [PDGFR]). G protein-coupled receptor kinases (GRK) directly regulate GPCR activity by phosphorylating activated agonist-bound receptors to desensitize signaling and internalize receptors through beta-arrestins. Recent studies in various cancers, including prostate and breast cancer, have highlighted the role of change in GRK expression to oncogenesis and tumor proliferation. In this study, we evaluated the expression of GRK5 in grade II to grade IV glioma specimens using immunohistochemistry and found that GRK5 expression levels are highly correlated with aggressiveness of glioma. We used culture conditions to selectively promote the growth of either glioblastoma cells with stem cell markers (GSC) or differentiated glioblastoma cells (DGC) from fresh GBM specimens. GSC are known to be highly invasive and mobile, and have the capacity to self-renew and are more resistant to chemotherapy and radiation compared to differentiated populations of GBM. We examined the expression of GRK5 in these two sets of culturing conditions for GBM cells and found that GRK5 expression is upregulated in GSC compared to differentiated GBM cells. To better understand the role of GRK5 in GBM-derived stem cells, we created stable GRK5 knockdown and evaluated the proliferation rate. Using an ATP chemiluminescence assay, we show, for the first time, that knocking down the expression of GRK5 decreased the proliferation rate of GSC in contrast to control.

AB - Glioblastoma multiforme (GBM) is a grade IV malignant brain tumor with high mortality and has been well known to involve many molecular pathways, including G-protein coupled receptor (GPCR)-mediated signaling (such as epithelial growth factor receptor [EGFR] and platelet derived growth factor receptor [PDGFR]). G protein-coupled receptor kinases (GRK) directly regulate GPCR activity by phosphorylating activated agonist-bound receptors to desensitize signaling and internalize receptors through beta-arrestins. Recent studies in various cancers, including prostate and breast cancer, have highlighted the role of change in GRK expression to oncogenesis and tumor proliferation. In this study, we evaluated the expression of GRK5 in grade II to grade IV glioma specimens using immunohistochemistry and found that GRK5 expression levels are highly correlated with aggressiveness of glioma. We used culture conditions to selectively promote the growth of either glioblastoma cells with stem cell markers (GSC) or differentiated glioblastoma cells (DGC) from fresh GBM specimens. GSC are known to be highly invasive and mobile, and have the capacity to self-renew and are more resistant to chemotherapy and radiation compared to differentiated populations of GBM. We examined the expression of GRK5 in these two sets of culturing conditions for GBM cells and found that GRK5 expression is upregulated in GSC compared to differentiated GBM cells. To better understand the role of GRK5 in GBM-derived stem cells, we created stable GRK5 knockdown and evaluated the proliferation rate. Using an ATP chemiluminescence assay, we show, for the first time, that knocking down the expression of GRK5 decreased the proliferation rate of GSC in contrast to control.

KW - GBM

KW - Glioblastoma derived stem cells

KW - GRK

KW - Proliferation

UR - http://www.scopus.com/inward/record.url?scp=84879007603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879007603&partnerID=8YFLogxK

U2 - 10.1016/j.jocn.2012.10.008

DO - 10.1016/j.jocn.2012.10.008

M3 - Article

C2 - 23693024

AN - SCOPUS:84879007603

VL - 20

SP - 1014

EP - 1018

JO - Journal of Clinical Neuroscience

JF - Journal of Clinical Neuroscience

SN - 0967-5868

IS - 7

ER -